Epithelial barrier and ion transport in coeliac sprue: electrical measurements on intestinal aspiration biopsy specimens
What Found Health Reports About Its Member Results Found Health's website presents several statistical claims that are worth understanding in context
Aaron Kesselheim, a pharmacoepidemiology and pharmacoeconomics expert who somehow always makes time for my random email requests and has a gift for explaining drugs and the complicated regulatory terrain
With higher water absorption, they stimulate significant collagen production while effectively targeting fat cells
Beautiful I bought the color MILKY MOCHA and I think it is one of the most beautiful colors in this collection
Sources Novo Nordisk NDA filing for CagriSema, December 18, 2025 American Diabetes Association REDEFINE-1 and REDEFINE-2 results, ADA 2026 Scientific Sessions HCPLive REDEFINE-1 Phase 3 safety and efficacy data Clinical Trials Arena REDEFINE-4: CagriSema vs tirzepatide head-to-head, February 2026 Life Science Daily News CagriSema FDA review timeline and NDA update, July 2026 PharmExec REDEFINE-1 results: CagriSema falls short of 25% weight loss target Drugs.com CagriSema FDA approval status history New England Journal of Medicine REDEFINE-1 full publication (presented at ADA 2026) Novo Nordisk REIMAGINE Phase 3 diabetes trial results, ADA 2026 and The Lancet FDA Wegovy (semaglutide) prescribing information, 2025 Related reading on Heally: What is Wegovy HD